|
NSMCE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.294170E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.132000E-01 |
| Normal-vs-Stage2 |
3.593600E-01 |
| Normal-vs-Stage3 |
1.483980E-01 |
| Normal-vs-Stage4 |
3.712000E-01 |
| Stage1-vs-Stage2 |
8.167600E-01 |
| Stage1-vs-Stage3 |
6.241800E-01 |
| Stage1-vs-Stage4 |
8.906600E-01 |
| Stage2-vs-Stage3 |
9.146400E-01 |
| Stage2-vs-Stage4 |
7.829200E-01 |
| Stage3-vs-Stage4 |
6.024400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.040500E-02 |
| Normal-vs-AfricanAmerican |
8.818800E-01 |
| Normal-vs-Asian |
6.789000E-01 |
| Caucasian-vs-AfricanAmerican |
3.074400E-01 |
| Caucasian-vs-Asian |
3.004400E-01 |
| AfricanAmerican-vs-Asian |
6.566800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.253800E-01 |
| Normal-vs-Female |
8.557500E-02 |
| Male-vs-Female |
3.071800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.636250E-01 |
| Normal-vs-Age(41-60Yrs) |
8.502000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.759800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.544400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.528800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.895600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.999200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.448400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.329600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.218000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.588820E-01 |
| Classical-VS-Follicular |
4.108000E-01 |
| Classical-VS-Other |
2.836800E-01 |
| Classical-VS-Normal |
1.670810E-01 |
| Tall-VS-Follicular |
1.207960E-01 |
| Tall-VS-Other |
2.654000E-02 |
| Tall-VS-Normal |
6.393700E-02 |
| Follicular-VS-Other |
2.550200E-01 |
| Follicular-VS-Normal |
7.843600E-01 |
| Other-VS-Normal |
3.944800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.677450E-01 |
| Normal-vs-N1 |
4.002400E-01 |
| N0-vs-N1 |
9.660400E-01 |
|
|
